Key result
PHACTR1 SNP rs9349379 reduces endothelial expression ~35% via altered MEF2 binding, linking it to CAD/MI risk.
The CAD/MI-associated SNP rs9349379 regulates PHACTR1 expression in the vascular endothelium via MEF2 binding, providing a mechanistic link for this genetic risk locus.
Answers are grounded in this paper and cite their sources.
PHACTR1 locus variants may refine CAD genetic risk scores; leaves open causal gene and downstream mechanisms.
OBJECTIVE: Coronary artery disease (CAD), including myocardial infarction (MI), is the main cause of death in the world. Genome-wide association studies have identified dozens of single nucleotide polymorphisms (SNPs) associated with CAD/MI. One of the most robust CAD/MI genetic associations is with intronic SNPs in the gene PHACTR1 on chromosome 6p24. How these PHACTR1 SNPs influence CAD/MI risk, and whether PHACTR1 itself is the causal gene at the locus, is currently unknown. APPROACH AND RESULTS: Using genetic fine-mapping and DNA resequencing experiments, we prioritized an intronic SNP (rs9349379) in PHACTR1 as causal variant. We showed that this variant is an expression quantitative trait locus for PHACTR1 expression in human coronary arteries. Experiments in endothelial cell extracts confirmed that alleles at rs9349379 are differentially bound by the transcription factors myocyte enhancer factor-2. We engineered a deletion of this myocyte enhancer factor-2-binding site using CRISPR/Cas9 genome-editing methodology. Heterozygous endothelial cells carrying this deletion express 35% less PHACTR1. Finally, we found no evidence that PHACTR1 expression levels are induced when stimulating human endothelial cells with vascular endothelial growth factor, tumor necrosis factor-α, or shear stress. CONCLUSIONS: Our results establish a link between intronic SNPs in PHACTR1, myocyte enhancer factor-2 binding, and transcriptional functions at the locus, PHACTR1 expression levels in coronary arteries and CAD/MI risk. Because PHACTR1 SNPs are not associated with the traditional risk factors for CAD/MI (eg, blood lipids or pressure, diabetes mellitus), our results suggest that PHACTR1 may influence CAD/MI risk through as yet unknown mechanisms in the vascular endothelium.
No takes yet. Share an insight, caveat, or question.
Beaudoin et al. (2015) studied Coronary artery disease (CAD) and myocardial infarction (MI). Intronic SNP (rs9349379) in PHACTR1 was evaluated on PHACTR1 expression levels and myocyte enhancer factor-2 binding. The intronic SNP rs9349379 in PHACTR1 alters myocyte enhancer factor-2 binding, reducing PHACTR1 expression by 35% in heterozygous endothelial cells, linking the locus to CAD/MI risk.
Synapse has enriched 10 related papers. Consider them for comparative context: